MagicMed Industries Inc. Featured in Virtual Coverage of Investor Summit Group’s Q1 Virtual Summit
MagicMed Industries Inc. intends to partner with pharmaceutical and other companies to develop and commercialize psychedelic-derived pharmaceutical candidates. MagicMed's psychedelic derivatives library, the Psybrary™, is intended to be an essential building block from which industry can develop new patented products. The initial focus of the Psybrary™ is on psilocybin and DMT derivatives, and the Psybrary™ is then expected to be expanded to other psychedelics such…